| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |